Embedded Files
Confidentiality: The patient’s identity is held in strict confidence and protected to the fullest extent. Programme staff is not expected to and will not disclose the reporter’s identity in response to a request from the public. Submission of a report does not constitute an admission that medical personnel or manufacturer or the product caused or contributed to the reaction.
Confidentiality: The patient’s identity is held in strict confidence and protected to the fullest extent. Programme staff is not expected to and will not disclose the reporter’s identity in response to a request from the public. Submission of a report does not constitute an admission that medical personnel or manufacturer or the product caused or contributed to the reaction.
Pharmacovigilance Programme of India for Assuring Drug Safety
Pharmacovigilance Programme of India for Assuring Drug Safety
How to fill in ADR Form-final.pdfHow to fill in the ADR reporting Form?
How to fill in the ADR reporting Form?
Fill in the Google Form of Suspected Adverse Drug Reaction Form for spontaneous reporting from COVID-19 Treating Ward/Facility.
Fill in the Google Form of Suspected Adverse Drug Reaction Form for spontaneous reporting from COVID-19 Treating Ward/Facility.
Click the link below
Click the link below
https://docs.google.com/forms/d/e/1FAIpQLSe8QIasHs2itDSdhjYVznIfy6fcqawZ2HSI3XcmQHSDMvHC8A/viewform
ADR Reporting Form for Covid 19 2020.pdfSuspected Adverse Drug Reaction Reporting Form
(For Drugs used in Prophylaxis & Treatment of COVID-19)
ADR-Reporting-Form1.3.pdfSuspected Adverse Drug Reaction Reporting Form
(For Voluntary Reporting of Adverse Drug Reactions by Health care Professionals)
consumers medicine side effect form in tamil.pdfMedicine Side Effect Reporting Form for Consumers/ Patients in TAMIL
ADR Reporting Form for Consumers in other Vernacular Languages
ADR Reporting Form for Consumers in other Vernacular Languages
What happens to the submitted information
What happens to the submitted information
Information provided in this form is handled in strict confidence.
The causality assessment is carried out at AMCs by using WHO-UMC scale.
The analyzed forms are forwarded to the NCC through ADR database.
Finally the data is analyzed and forwarded to the Global Pharmacovigilance Database managed by WHO Uppsala Monitoring Centre in Sweden.
The reports are periodically reviewed by the National Coordination Centre-Pharmacovigilance Programme of India.
The information generated on the basis of these reports helps in continuous assessment of the benefit-risk ratio of medicines.
The information is submitted to the Steering committee of PvPI constituted by the Ministry of Health & Family Welfare.
The Committee is entrusted with the responsibility to review the data and suggest any interventions that may be required
Page updated
Google Sites
Report abuse